Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06072976 · ClinicalTrials.gov registry record · NA
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
A NA study, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT06072976: Recruiting NA study, sponsored by Seattle Children's Hospital.
NCT06072976 is a NA study that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06072976, a NA study, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.
Primary Outcome
: In infants with congenital gastrointestinal pathologies (gastroschisis, giant omphalocele, atresia, midgut volvulus, Hirschsprung disease, CGP), to determine if use of an exclusive human milk diet will decrease the number of days to full feeding volume (120 ml/kg/day) (29 subjects per power calculation) compared to human milk/formula
Interventions
- DIETARY_SUPPLEMENT Standard of Care
- DIETARY_SUPPLEMENT Exclusive Human Milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2027-06-09 |
| Phase | NA |
What NCT06072976 shows while recruiting
NCT06072976 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT06072976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06072976 about?
NCT06072976 is a clinical study titled "The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies". This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.
What is the current status of trial NCT06072976?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2023-06-09. Estimated completion is 2027-06-09.
What interventions are being tested in trial NCT06072976?
The interventions under investigation include: Standard of Care (DIETARY_SUPPLEMENT), Exclusive Human Milk (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06072976?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06072976's enrollment target sits among peer trials
116 808th of 2000 higher than 1,191 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI